{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:15:46Z","timestamp":1754194546413,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-021-00772-2","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T07:04:53Z","timestamp":1636614293000},"page":"613-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of immunological features with clinical manifestations in primary Sjogren\u2019s syndrome: a single-center cross-sectional study"],"prefix":"10.1007","volume":"22","author":[{"given":"Hitesh Srinivasa Krishna","family":"Relangi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9727-044X","authenticated-orcid":false,"given":"G. S. R. S. N. K.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shefali K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana W.","family":"Minz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"issue":"Suppl","key":"772_CR1","first-page":"54","volume":"54","author":"KM Mahendranath","year":"2006","unstructured":"Mahendranath KM. Sjogren\u2019s syndrome-diagnosis and management. J Assoc Physicians India. 2006;54(Suppl):54\u20137.","journal-title":"J Assoc Physicians India"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren\u2019s syndrome. Autoimmun Rev. 2010;9:A305\u201310.","journal-title":"Autoimmun Rev"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1874312901409010036","volume":"9","author":"P Sandhya","year":"2015","unstructured":"Sandhya P, Jayaseelan L, Scofield RH, Danda D. Clinical characteristics and outcome of primary Sjogren\u2019s syndrome: A large Asian Indian cohort. Open Rheumatol J. 2015;9:36\u201345.","journal-title":"Open Rheumatol J"},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2004.12.002","volume":"4","author":"H Locht","year":"2005","unstructured":"Locht H, Pelck R, Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sj\u00f6gren\u2019s syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev. 2005;4:276\u201381.","journal-title":"Autoimmun Rev"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s10875-011-9553-3","volume":"31","author":"C Martel","year":"2011","unstructured":"Martel C, Gondran G, Launay D, et al. Active immunological profile is associated with systemic Sj\u00f6gren\u2019s syndrome. J Clin Immunol. 2011;31:840\u20137.","journal-title":"J Clin Immunol"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/ard.60.5.467","volume":"60","author":"M Pertovaara","year":"2001","unstructured":"Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sj\u00f6gren\u2019s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis. 2001;60:467\u201372.","journal-title":"Ann Rheum Dis"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, et al. Primary Sj\u00f6gren\u2019s syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87:210\u20139.","journal-title":"Medicine (Baltimore)"},{"key":"772_CR8","first-page":"3252","volume":"123","author":"DF Lin","year":"2010","unstructured":"Lin DF, Yan SM, Zhao Y, et al. Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren\u2019s syndrome. Chin Med J (Engl). 2010;123:3252\u20137.","journal-title":"Chin Med J (Engl)"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7326\/0003-4819-98-2-155","volume":"98","author":"EL Alexander","year":"1983","unstructured":"Alexander EL, Arnett FC, Provost TT, Stevens MB. Sj\u00f6gren\u2019s syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155\u20139.","journal-title":"Ann Intern Med"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3904\/kjim.1997.12.2.176","volume":"12","author":"CS Cho","year":"1997","unstructured":"Cho CS, Park SH, Min JK, Lee SH, Kim HY. Clinical significances of antibodies to Ro\/SS-A autoantigens and its subtypes in primary Sjogren\u2019s syndrome. Korean J Intern Med. 1997;12:176\u201381.","journal-title":"Korean J Intern Med"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zeron P, Yague J, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome. Rheumatology (Oxford). 2005;44:89\u201394.","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","volume":"10","author":"G Hern\u00e1ndez-Molina","year":"2011","unstructured":"Hern\u00e1ndez-Molina G, Leal-Alegre G, Michel-Peregrina M. The meaning of anti-Ro and anti-La antibodies in primary Sj\u00f6gren\u2019s syndrome. Autoimmun Rev. 2011;10:123\u20135.","journal-title":"Autoimmun Rev"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2014","unstructured":"Baldini C, Pepe P, Quartuccio L, et al. Primary Sj\u00f6gren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford). 2014;53:839\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 112","key":"772_CR14","first-page":"102","volume":"36","author":"P Brito-Zer\u00f3n","year":"2018","unstructured":"Brito-Zer\u00f3n P, Acar-Denizli N, Ng WF, et al. How immunological profile drives clinical phenotype of primary Sj\u00f6gren\u2019s syndrome at diagnosis: analysis of 10,500 patients (Sj\u00f6gren big data project). Clin Exp Rheumatol. 2018;36(Suppl. 112):102\u201312.","journal-title":"Clin Exp Rheumatol"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","volume":"46","author":"P Brito-Zer\u00f3n","year":"2007","unstructured":"Brito-Zer\u00f3n P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sj\u00f6gren\u2019s syndrome: identification of prognostic factors. Rheumatology (Oxford). 2007;46:1359\u201362.","journal-title":"Rheumatology (Oxford)"},{"key":"772_CR16","first-page":"686","volume":"30","author":"S Retamozo","year":"2012","unstructured":"Retamozo S, Akasbi M, Brito-Zer\u00f3n P, et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2012;30:686\u201392.","journal-title":"Clin Exp Rheumatol"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 ACR-EULAR classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69:35\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2010;69:1103\u20139.","journal-title":"Ann Rheum Dis"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0973-3698.192690","volume":"11","author":"K Mohanasundaram","year":"2016","unstructured":"Mohanasundaram K, Mani M, Chinnadurai S, et al. Study on demography and outcome of extraglandular manifestations of primary Sj\u00f6gren\u2019s syndrome. Indian J Rheumatol. 2016;11:202\u20136.","journal-title":"Indian J Rheumatol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00772-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00772-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T22:11:56Z","timestamp":1666563116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00772-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00772-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted after approval by the Institute Ethics Committee and the study complies with the Declaration of Helsinki. A written informed consent was obtained from all subjects before being enrolled in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}